Polpharma Pursues Tysabri Through Antelope Trial

First Patients Recruited In Poland

 
• By Aidan Fry
  
Hunting
Polpharma Biologics is pursuing a biosimilar of Tysabri through its Antelope Phase III clinical study • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products